Science (journal)

Revolutionary Scientists Honored for Advancements in Gene Therapy for Neuromuscular Diseases and RNA Discoveries: King Faisal Prize Laureates in Medicine, Professor Jerry Mendell, and in Science, Professor Howard Chang, Awarded

Retrieved on: 
Monday, April 22, 2024
Science (journal), Mortality, FDA, Pediatric Research, Protein, Chromatin, Cell, Limb–girdle muscular dystrophy, Research, American Philosophical Society, National Cancer Institute, Molecular biology, Life, Gene, Quran, Food, LGMD, SMA, RNA, DMD, Spinal muscular atrophy, Infant, Dystrophin, Nationwide, Duchenne muscular dystrophy, Ageing, National academy, Hospital, Cancer research, Literature, DNA, Therapy, Gene expression, Muscular dystrophy, Chromosome, USD, Stanford University, Cancer, Islamic studies, Muscle weakness, Disease, Vilcek Foundation, Patient, Assay, Society, Listeria monocytogenes non-coding RNA, Pharmaceutical industry

Genetic mutations in Duchenne muscular dystrophy (DMD) patients hinder the production of dystrophin, a crucial protein for muscle health.

Key Points: 
  • Genetic mutations in Duchenne muscular dystrophy (DMD) patients hinder the production of dystrophin, a crucial protein for muscle health.
  • Gene therapy offers a solution by addressing this genetic anomaly, allowing the body to produce dystrophin and halt muscle degeneration.
  • Ludwig Professor of Cancer Research at Stanford University, has been awarded King Faisal Prize for Science in Biology.
  • Since 1979, King Faisal Prize in its 5 different categories has awarded 295 laureates who have made distinguished contributions to different sciences and causes.

National Experts in Psychology, Addiction Counseling, and Clinical Services Join Kyros' Inaugural Independent Clinical Advisory Board

Retrieved on: 
Tuesday, February 20, 2024
Social media, Mental health, LPCC, Doctor of Philosophy, DBT, Education, Kyros, Substance abuse, Nash, Gait, Social determinants of health, City, Dialectical behavior therapy, Medical diagnosis, Helwig, Locomotion, The New York Times, Health, SDOH, DNP, University, Collaboration, EEG, Certification, Psychology, Executive, Policy, Employment, Statistics, Magnetic resonance, Publication, Science, Science (journal), Housing, Disability studies, Social, Research, University of Minnesota, Partnership, Nursing

MINNEAPOLIS, Feb. 20, 2024 /PRNewswire/ -- In a significant move to strengthen its commitment to addressing substance use disorders and enhancing community recovery efforts, Kyros is excited to announce the establishment of its Independent Clinical Advisory Board and the following appointments:

Key Points: 
  • The Clinical Advisory Board's mission is to independently advise Kyros leadership on improving care and outcomes for individuals with substance use disorders.
  • It does this by providing evidence-based recommendations, promoting collaboration among stakeholders, and driving continuous improvement in recovery care services.
  • Professor Helwig is the author of 10 open-source statistical software packages, which have amassed over 1,000,000 downloads in recent years.
  • Their profound expertise will play a pivotal role in tackling urgent issues such as the opioid epidemic, dual diagnosis, and the need for comprehensive recovery support services."

Alnylam CEO Yvonne Greenstreet Named 2024 Woman of the Year by Healthcare Businesswomen’s Association

Retrieved on: 
Tuesday, January 9, 2024
Biotechnology, Pharmaceutical, Health, BIO, Patient, GSK plc, Mentorship, Bloomberg, Medication, Health care, Health equity, Alnylam Pharmaceuticals, Harvard Medical School, University of Leeds, GSK, Capital Group Companies, Science, Science (journal), Workplace, RNA interference, Environment, MBA, Conference, HBA, Biotechnology Innovation Organization, HSGB, University, Therapy, Research, Parent, Growth, Management

Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, said today that Chief Executive Officer Yvonne Greenstreet has been selected as the 2024 Woman of the Year by the Healthcare Businesswomen’s Association (HBA).

Key Points: 
  • Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, said today that Chief Executive Officer Yvonne Greenstreet has been selected as the 2024 Woman of the Year by the Healthcare Businesswomen’s Association (HBA).
  • Yvonne will be recognized at HBA’s 34th annual Woman of the Year event on May 10 in New York City.
  • The HBA Woman of the Year award honors an executive leader who has made extraordinary contributions to healthcare and the advancement of women in the workplace.
  • “Yvonne demonstrates leadership from the front,” said David Pyott, retired chairman and CEO of Allergan and a member of Alnylam’s board of directors.

Healthcare Industry Equity Champions Announced as 2024 Award Recipients by the Healthcare Businesswomen's Association

Retrieved on: 
Tuesday, January 9, 2024
Merck & Co., RNA interference, Sustainability, Science, Harvard Medical School, Annual, ARD International Music Competition, GSK plc, Woman of the Year, Respect, Growth, Medication, STAR, RNA, Capital Group Companies, Science (journal), Merck Group, Female, Male, Mentorship, Workplace, ICON, Organizational founder, Trailblazer, Informatics, Patient, Bloomberg, Nobel, Syneos Health, Pfizer, HBA, Merck, Parent, SVP

FAIRFIELD, N.J., Jan. 9, 2024 /PRNewswire/ -- The Healthcare Businesswomen's Association (HBA) announces the 2024 Woman of the Year, Honorable Mentor, and STAR. Recognized for their outstanding contributions to healthcare and the advancement of women in the workplace, the honorees will be celebrated at HBA's 34th annual Woman of the Year event on 10 May in New York City and remotely around the globe.

Key Points: 
  • FAIRFIELD, N.J., Jan. 9, 2024 /PRNewswire/ -- The Healthcare Businesswomen's Association (HBA) announces the 2024 Woman of the Year, Honorable Mentor, and STAR.
  • Dr. Otis Johnson, Co-founder & Principal Consultant, Trial Equity, is the recipient of the HBA Honorable Mentor award.
  • "The HBA is proud to recognize and showcase this year's award recipients for their notable and remarkable commitment and valuable contributions to women in the healthcare ecosystem," said Mary Stutts, CEO, HBA.
  • He is a stellar example of the lasting change that advocacy and allyship can bring about in the healthcare industry.

23andMe Reports Second Quarter Fiscal 2024 Financial Results

Retrieved on: 
Wednesday, November 8, 2023
FDA, Research, African Americans, 23andMe, PGS, Health, Science, CORE (research service), Society for Immunotherapy of Cancer, Behavior, BRCA1, Consumer, Genetics, EBITDA, Workforce, Health Action International, Premium, Bangladesh Technical Education Board, Inflammation, BRCA2, DNA, Advertising, Pharmacokinetics, Consumer service, SITC, Science (journal), Immunotherapy, Database, Growth, Marketing, Webcast, GSK, GSK plc, Blood, Society, African, Total, Table, Pharmacogenomics, Harvard University, Lijun International Pharmaceutical (Holding) Co. Ltd., SAN, Pharmaceutical industry, Mobile phone, CD200R1, Simvastatin, Therapy

SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the second quarter of fiscal year 2024 (FY24), which ended September 30, 2023.

Key Points: 
  • SOUTH SAN FRANCISCO, Calif., Nov. 08, 2023 (GLOBE NEWSWIRE) -- 23andMe Holding Co. (Nasdaq: ME), a leading human genetics and biopharmaceutical company, reported its financial results for the second quarter of fiscal year 2024 (FY24), which ended September 30, 2023.
  • Members of Total Health will also receive all the reports and features offered in our existing 23andMe+ Premium Membership.
  • Full year Adjusted EBITDA deficit is reaffirmed to be in the range of $180 to $160 million for fiscal year 2024.
  • 23andMe will host a conference call at 4:30 p.m. Eastern Time today, November 8, 2023, to discuss the financial results for Q2 FY2024 and report on business progress.

Osmoses Secures $11M to Decarbonize Projected $35B Industrial Gas Separation Market with Novel Membrane Technology

Retrieved on: 
Tuesday, October 3, 2023
Technology, Other Natural Resources, Other Energy, Other Technology, Natural Resources, Green Technology, Oil, Gas, Alternative Energy, Environment, Energy, Sustainability, Merck Millipore, U.S. Department of Energy, Office of Inspector General, Science, Collaborative Fund, U.S. Department of Defense Strategy for Operating in Cyberspace, Associate professor, Hydrogen, NSF, Oxygen, Distillation, Multimedia, Carbon, DOE, IRA, Doctor of Philosophy, ARPA, Organization, Membrane, Inflation, Chemical substance, Climate change, MIT Department of Mathematics, Inflation Reduction Act of 2022, Chemical engineering, Family, CO2, Natural gas, Renewable energy, Engineering, Science (journal), Osmose New Zealand Ltd v Wakeling

Osmoses will use the funding to develop commercial scale membrane modules for field deployment and establish pilot partnerships.

Key Points: 
  • Osmoses will use the funding to develop commercial scale membrane modules for field deployment and establish pilot partnerships.
  • Today’s industrial separation processes, including cryogenic processes, distillation, and solvent absorption, account for 15% of the world’s energy consumption .
  • CO2 emissions from energy combustion and industrial processes accounted for 89% of energy-related greenhouse gas emissions in 2022.
  • Osmoses can also power profitable hybrid separation system designs for low feed concentrations such as those in hydrogen de-blending and helium recovery.

Pasithea Therapeutics Chairman, Prof. Lawrence Steinman, to Deliver Keynote Address at the American Association for Advancement of Science (AAAS) Annual Meeting

Retrieved on: 
Thursday, March 2, 2023
American Association for the Advancement of Science, Annual general meeting, Association of Environmental Engineering and Science Professors, Research, CNS, Science (journal), National academy, Attention, MS, Multiple sclerosis, Central nervous system, National Academy of Sciences, PALO, AAAS, KTTA, Pharmaceutical industry, Science

AAAS is the world's largest general scientific society, with over 120,000 members, and is the publisher of the scientific journal Science.

Key Points: 
  • AAAS is the world's largest general scientific society, with over 120,000 members, and is the publisher of the scientific journal Science.
  • Prof. Steinman's research on the link between the Epstein-Barr virus and multiple sclerosis (MS) was a runner-up for the 2022 Science Magazine Breakthrough of the Year.
  • “I’m honored to be asked to address such an important assembly of scientists and to share insight on this critical work with peers,” commented Dr. Steinman.
  • “Recognition of the work by Science is thrilling because of the attention it brings to our effort to fight MS.”

Shannon Illingworth, Founder of GP Solutions, Wants You to Know Why Tomatoes in America Are Flavorless

Retrieved on: 
Wednesday, December 14, 2022
Food, Plant, Niacin, Herbicide, NPR, C, Science, Calcium, Rodenticide, Vegetable, Disease, Science (journal), Pesticide, Ticker, Risk, Agriculture

CORONA, Calif., Dec. 14, 2022 /PRNewswire/ -- GP Solutions, Inc (Ticker: GWPD), announced that company founder, Shannon Illingworth, is speaking out about the tomato industry in America. His new organization, "Know the Grow," is dedicated to educating the public about where and how food is grown in America.

Key Points: 
  • CORONA, Calif., Dec. 14, 2022 /PRNewswire/ -- GP Solutions, Inc (Ticker: GWPD), announced that company founder, Shannon Illingworth, is speaking out about the tomato industry in America.
  • His new organization, "Know the Grow," is dedicated to educating the public about where and how food is grown in America.
  • "For the last 50 or more years, tomato breeders have concentrated essentially on one thing and that is yield," Estabrook told NPR .
  • Shannon Illingworth, Founder of GP Solutions, and the inventor of GrowPods, said most people don't even know what a normal tomato is supposed to look like.

"Hothouse Earth" and US Surprise Climate Bill Debunked by NASA Award-winning Scientist's Research says Friends of Science

Retrieved on: 
Thursday, August 4, 2022
Carbon, Famine, Schumer, Temperature, Climate change, Bell MTS Place, MPA, Goal, Maguire, Science Society of China, United Nations Framework Convention on Climate Change, Climate, Food, Science (journal), JPMorgan Chase, Fear, Friends of Science, Carbon dioxide, PNAS, Pacific Northwest, Energy, Domicile (law), Review, NetZero, Literature, Energy Information Administration, NASA, Road, GHG, Death, CO2, Friends, ABC, Extinction Rebellion, Environment, RCP, UNFCCC, Renewable energy, Agriculture, Low-carbon economy, Science, Greenhouse and icehouse Earth

CALGARY, Alberta, Aug. 4, 2022 /PRNewswire-PRWeb/ -- As reported by Science Insider on Aug. 1, 2022, the US has embarked on efforts to pass a $369 billion dollar climate plan, but they will be met with Speed Bumps on the Road to Decarbonization, and Hazards Ahead, says Friends of Science Society. The impossibility of attaining most climate and 'transition' goals, especially in the short term, are clearly outlined in these Robert Lyman summary reports of a pragmatic JP Morgan analysis. Proponents claim the surprise bill will meet the ambitious goal of a 40% reduction in emissions, noting that 'more action' is needed to meet the goal of cutting emissions in half by 2030.

Key Points: 
  • The fear of a climate catastrophe due to rising carbon dioxide levels is debunked by the work of Dr. Roy Spencer, NASA award-winning scientist.
  • The van Vliet-Lano research rebutting the 'climate change killer' construct is presented in a plain language video by Friends of Science Society.
  • Now is not the time to embark on wasteful climate change policies based on ideology, says Friends of Science.
  • Friends of Science Society is an independent group of earth, atmospheric and solar scientists, engineers, and citizens that is celebrating its 20th year of offering climate science insights.

DNAverse creates the first NFT collection customized with real DNA in the Metaverse

Retrieved on: 
Monday, March 7, 2022
Movement, Life, Protein Data Bank, Science (journal), Genetics, DNA, NFT, Science, Science Magazine (TV series), Blockchain, Communication, CEO, Non-fungible token, AI, Collection, Cryptocurrency, Metaverse

MADRID, March 7, 2022 /PRNewswire/ -- 3DforScience is thrilled to announce the launch of DNAverse , the world's first project to integrate users' real DNA data into customized artwork NFTs.

Key Points: 
  • MADRID, March 7, 2022 /PRNewswire/ -- 3DforScience is thrilled to announce the launch of DNAverse , the world's first project to integrate users' real DNA data into customized artwork NFTs.
  • Based on Science Magazine's Breakthrough of the Year 2021 , this project paves the way towards a genetic metaverse.
  • Each NFT is one-to-one handcrafted and includes a genetic study and a fully personalized artistic interpretation of collectors' own DNA (DNArts).
  • DNAVERSE is the world's first art NFT collection customized with real DNA data, built upon a utility business model that initiates the BIOmetaverse.